143 related articles for article (PubMed ID: 34284951)
1. Enhancing capsule in hepatocellular carcinoma: intra-individual comparison between CT and MRI with extracellular contrast agent.
Cannella R; Ronot M; Sartoris R; Cauchy F; Hobeika C; Beaufrere A; Trapani L; Paradis V; Bouattour M; Bonvalet F; Vilgrain V; Dioguardi Burgio M
Diagn Interv Imaging; 2021 Dec; 102(12):735-742. PubMed ID: 34284951
[TBL] [Abstract][Full Text] [Related]
2. Imaging Features of Hepatocellular Carcinoma: Quantitative and Qualitative Comparison Between MRI-Enhanced With Gd-EOB-DTPA and Gd-DTPA.
Son J; Hwang SH; Park S; Han K; Chung YE; Choi JY; Kim MJ; Park MS
Invest Radiol; 2019 Aug; 54(8):494-499. PubMed ID: 31094878
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography.
Min JH; Kim JM; Kim YK; Cha DI; Kang TW; Kim H; Choi GS; Choi SY; Ahn S
Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2091-2100.e7. PubMed ID: 31843599
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic performance of contrast-enhanced CT versus extracellular contrast agent-enhanced MRI in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.
Chen X; Li M; Guo R; Liu W; Li J; Zong X; Chen Q; Wang J
Abdom Radiol (NY); 2022 Jun; 47(6):2057-2070. PubMed ID: 35312822
[TBL] [Abstract][Full Text] [Related]
5. Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.
Chernyak V; Flusberg M; Law A; Kobi M; Paroder V; Rozenblit AM
J Comput Assist Tomogr; 2018; 42(1):155-161. PubMed ID: 28806321
[TBL] [Abstract][Full Text] [Related]
6. Targetoid appearance on T2-weighted imaging and signs of tumor vascular involvement: diagnostic value for differentiating HCC from other primary liver carcinomas.
Cannella R; Fraum TJ; Ludwig DR; Borhani AA; Tsung A; Furlan A; Fowler KJ
Eur Radiol; 2021 Sep; 31(9):6868-6878. PubMed ID: 33590319
[TBL] [Abstract][Full Text] [Related]
7. Intraindividual Comparison of Hepatocellular Carcinoma Washout between MRIs with Hepatobiliary and Extracellular Contrast Agents.
Kim YY; Kim YK; Min JH; Cha DI; Kim JM; Choi GS; Ahn S
Korean J Radiol; 2021 May; 22(5):725-734. PubMed ID: 33660458
[TBL] [Abstract][Full Text] [Related]
8. Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.
Lee SE; An C; Hwang SH; Choi JY; Han K; Kim MJ
Eur Radiol; 2018 Apr; 28(4):1551-1559. PubMed ID: 29134355
[TBL] [Abstract][Full Text] [Related]
9. Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs.
Paisant A; Vilgrain V; Riou J; Oberti F; Sutter O; Laurent V; Rodes A; Guiu B; Cassinotto C; Trillaud H; Bricault I; Michalak S; Bruno O; Ronot M; Aubé C
J Hepatol; 2020 May; 72(5):937-945. PubMed ID: 31870951
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI.
Yim JH; Kim YK; Min JH; Lee J; Kang TW; Lee SJ
Abdom Radiol (NY); 2019 Jul; 44(7):2366-2376. PubMed ID: 30847566
[TBL] [Abstract][Full Text] [Related]
11. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
Ehman EC; Behr SC; Umetsu SE; Fidelman N; Yeh BM; Ferrell LD; Hope TA
Abdom Radiol (NY); 2016 May; 41(5):963-9. PubMed ID: 27193793
[TBL] [Abstract][Full Text] [Related]
12. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria.
Yoon JK; Han DH; Lee S; Choi JY; Choi GH; Kim DY; Kim MJ
Cancer Res Treat; 2023 Jul; 55(3):939-947. PubMed ID: 36791769
[TBL] [Abstract][Full Text] [Related]
14. Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS.
Kim YC; Min JH; Kim YK; Lee SJ; Ahn S; Kim E; Peeters H
Eur Radiol; 2019 Apr; 29(4):2058-2068. PubMed ID: 30324388
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of MRI for HCC according to contrast agent type: a systematic review and meta-analysis.
Kim DW; Choi SH; Kim SY; Byun JH; Lee SS; Park SH; Kim KW
Hepatol Int; 2020 Dec; 14(6):1009-1022. PubMed ID: 33146841
[TBL] [Abstract][Full Text] [Related]
16. Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System.
Min JH; Kim JM; Kim YK; Kang TW; Lee SJ; Choi GS; Choi SY; Ahn S
Hepatology; 2018 Dec; 68(6):2254-2266. PubMed ID: 30070365
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
18. Ring-like enhancement on Contrast-Enhanced ultrasound may correlate well with histopathological capsule of Hepatocellular Carcinoma: Comparison with the enhancing capsule on Gadopentetate-enhanced MRI.
Bo J; Xiang F; XiaoWei F; LianHua Z; YuKun L
Eur J Radiol; 2023 May; 162():110762. PubMed ID: 36934636
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
